Some of the priorities were drawn from the World Health Organisation’s Roadmap; others were expressed by researchers in and from Africa as being important to the continent’s many contexts.
History shows that treatments and vaccines have been accessible to African countries only after the loss of millions of lives and typically years - sometimes decades - after developed nations.
It is only with comparable data that scientists can assess whether the measures they implement are effective in protecting citizens, and better prepare for future health crises.
South Africa’s public health system has been allocated R21.5 billion more for the fight against the COVID-19 pandemic but there’s no strategy to guide how it should be used.
Most facilities prioritize COVID-19 cases. In addition, curfews are still in effect in Kenya, which affects the working hours of clinics providing hypertension care services.
Pandemic histories are useful for understanding COVID-19, but how they connect with race, public health, revolution, labour and colonialism are needed to explain the present and predict the future.
The Freedom Charter process was an imperfect but impressive attempt at capturing the will of the people and articulating an alternative vision to apartheid South Africa.
In a country marred by systematic discrimination and continued social marginalisation, particular consideration needs to be given to the measures being used to contain the spread of COVID-19.
Monica Gandhi, University of California, San Francisco
There is a lot of confusion and concern around asymptomatic spread of SARS-C0V-2. An infectious disease expert explains how many people are asymptomatic and how they can spread the virus.
Stay-at-home orders and social distancing make technology all the more important for maintaining human connections. They also make it easier for abusers to use technology against their victims.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town